1. Home
  2. SNY
  3. SNY News

Latest Sanofi ADS (SNY) News on November 21, 2024

Here’s What Drove Sanofi’s (SNY) Earnings
SNY

Insider Monkey

a day ago

Here’s What Drove Sanofi’s (SNY) Earnings

Sanofi: Information concerning the total number of voting rights and shares - October 2024
SNY

GlobeNewswire

a day ago

Sanofi: Information concerning the total number of voting rights and shares - October 2024

FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria
SNY

Zacks

3 days ago

FDA Accepts SNY and REGN's Dupixent Re-Submitted sBLA for Urticaria

SNY

Argus Research

3 days ago

Weekly Stock List

SNY

Morningstar Research

3 days ago

Analyst Report: Sanofi

How analysts are reacting to RFK Jr. as Trump's HHS pick
SNY

Yahoo Finance Video

6 days ago

How analysts are reacting to RFK Jr. as Trump's HHS pick

Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell?
SNY

Investor's Business Daily

6 days ago

Novavax Cut Its Outlook Despite Beating Third-Quarter Forecasts. Is It A Sell?

FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
SNY

Pharmaceutical Technology

6 days ago

FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria

Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of.
SNY

Yahoo Finance

6 days ago

Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of.

Trump’s RFK Jr. Pick Weighs on Vaccine Makers
SNY

The Wall Street Journal

6 days ago

Trump’s RFK Jr. Pick Weighs on Vaccine Makers

Stocks to Watch Friday: Alibaba, Domino's, Palantir, Ulta Beauty
SNY

The Wall Street Journal

6 days ago

Stocks to Watch Friday: Alibaba, Domino's, Palantir, Ulta Beauty

RFK Jr. News Hits Global Pharma Stocks
SNY

The Wall Street Journal

6 days ago

RFK Jr. News Hits Global Pharma Stocks

European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department
SNY

The Wall Street Journal

6 days ago

European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department

EMA’s CHMP recommends Sanofi’s Sarclisa approval for multiple myeloma
SNY

Pharmaceutical Technology

6 days ago

EMA’s CHMP recommends Sanofi’s Sarclisa approval for multiple myeloma

SNY

MT Newswires

6 days ago

Regeneron Pharmaceuticals, Sanofi Say FDA Accepts Application for Skin Disease Treatment

Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria
SNY

GlobeNewswire

6 days ago

Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria

Top Analyst Reports for UnitedHealth, Bank of America & SAP
SNY

Zacks

8 days ago

Top Analyst Reports for UnitedHealth, Bank of America & SAP

Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
SNY

Benzinga

8 days ago

Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease

Novavax Q3 Earnings & Sales Beat, Stock Falls 6% on '24 View Cut
SNY

Zacks

8 days ago

Novavax Q3 Earnings & Sales Beat, Stock Falls 6% on '24 View Cut

Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial ...
SNY

GuruFocus.com

8 days ago

Novavax Inc (NVAX) Q3 2024 Earnings Call Highlights: Strategic Partnerships and Financial ...

Novavax stock plunges after quarterly earnings, but company sees hope in licensing deals
SNY

Yahoo Finance

9 days ago

Novavax stock plunges after quarterly earnings, but company sees hope in licensing deals

Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales
SNY

Reuters

9 days ago

Novavax cuts 2024 revenue forecast again on lower COVID vaccine sales

SNY

Argus Research

10 days ago

Daily Spotlight: A Range of Options Among Sovereign Debt Yields

SNY

GuruFocus.com

10 days ago

Recordati SpA (RICFY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

Denali Q3 Earnings Miss Estimates, Pipeline Progress Encouraging
SNY

Zacks

13 days ago

Denali Q3 Earnings Miss Estimates, Pipeline Progress Encouraging

SNY

Morningstar Research

13 days ago

Analyst Report: Sanofi

Advent Mulls €5 Billion Sale of Generic Drugmaker Zentiva
SNY

Bloomberg

14 days ago

Advent Mulls €5 Billion Sale of Generic Drugmaker Zentiva

EMA approves Sanofi/Regeneron’s Dupixent for young EoE patients
SNY

Pharmaceutical Technology

14 days ago

EMA approves Sanofi/Regeneron’s Dupixent for young EoE patients

SNY

MT Newswires

15 days ago

Sanofi, Regeneron Receive European Pediatric Approval for Throat Disease Treatment

Press Release: Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitis
SNY

GlobeNewswire

15 days ago

Press Release: Dupixent approved in the EU as the first and only medicine for young children with eosinophilic esophagitis

Dupixent® (dupilumab) Approved in the European Union as the First and Only Medicine for Young Children with Eosinophilic Esophagitis
SNY

GlobeNewswire

15 days ago

Dupixent® (dupilumab) Approved in the European Union as the First and Only Medicine for Young Children with Eosinophilic Esophagitis

Vir Biotechnology Inc (VIR) Q3 2024 Earnings Call Highlights: Strategic Restructuring and ...
SNY

GuruFocus.com

20 days ago

Vir Biotechnology Inc (VIR) Q3 2024 Earnings Call Highlights: Strategic Restructuring and ...

Kymera Q3 Loss Narrower Than Expected, Pipeline in Focus
SNY

Zacks

20 days ago

Kymera Q3 Loss Narrower Than Expected, Pipeline in Focus

Kymera Therapeutics Inc (KYMR) Q3 2024 Earnings Call Highlights: Strategic Advancements and ...
SNY

GuruFocus.com

20 days ago

Kymera Therapeutics Inc (KYMR) Q3 2024 Earnings Call Highlights: Strategic Advancements and ...

REGN Q3 Earnings and Revenues Beat on Strong Eylea HD & Dupixent Sales
SNY

Zacks

21 days ago

REGN Q3 Earnings and Revenues Beat on Strong Eylea HD & Dupixent Sales

SNY

Thomson Reuters StreetEvents

22 days ago

Q3 2024 BioMarin Pharmaceutical Inc Earnings Call

SNY

MT Newswires

23 days ago

Sanofi Partners with SandboxAQ on AI-Driven Drug Discovery

Beyfortus® immunization to protect infants from RSV has begun
SNY

CNW Group

24 days ago

Beyfortus® immunization to protect infants from RSV has begun

Regeneron to Report Q3 Earnings: What's in the Offing?
SNY

Zacks

24 days ago

Regeneron to Report Q3 Earnings: What's in the Offing?

SNY

Argus Research

24 days ago

Market Digest: SNY, CME, HOG, PCAR, LEA, VLTO

SNY

Argus Research

24 days ago

Analyst Report: Sanofi SA

Sanofi SA (SNY) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Advances
SNY

GuruFocus.com

a month ago

Sanofi SA (SNY) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Strategic Advances

SNY

Morningstar Research

a month ago

Analyst Report: Sanofi

Why Sanofi Stock Flew Higher on Friday
SNY

Motley Fool

a month ago

Why Sanofi Stock Flew Higher on Friday

Sanofi (SNY) Q3 2024 Earnings Call Transcript
SNY

Motley Fool

a month ago

Sanofi (SNY) Q3 2024 Earnings Call Transcript

Pharma Stock Roundup: RHHBY Earnings, Drug Pipeline & Regulatory News
SNY

Zacks

a month ago

Pharma Stock Roundup: RHHBY Earnings, Drug Pipeline & Regulatory News

Eli Lilly's Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron's Dupixent
SNY

Benzinga

a month ago

Eli Lilly's Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron's Dupixent

Sanofi Shocks the Market: Massive Q3 Surge, Game-Changing Moves, and Bold Divestment Plans
SNY

GuruFocus.com

a month ago

Sanofi Shocks the Market: Massive Q3 Surge, Game-Changing Moves, and Bold Divestment Plans

Sanofi Q3 Earnings Beat, Dupixent, New Drugs, Vaccines Drive Sales
SNY

Zacks

a month ago

Sanofi Q3 Earnings Beat, Dupixent, New Drugs, Vaccines Drive Sales

Sanofi-backed Agomab raises $89m to advance fibrotic disease treatments
SNY

Pharmaceutical Technology

a month ago

Sanofi-backed Agomab raises $89m to advance fibrotic disease treatments

Sanofi Eyes Breakout After Pharma Titan Rides Vaccine Sales To Quarterly Beat
SNY

Investor's Business Daily

a month ago

Sanofi Eyes Breakout After Pharma Titan Rides Vaccine Sales To Quarterly Beat

SNY

MT Newswires

a month ago

Sector Update: Health Care Stocks Advance Pre-Bell Friday

Sanofi Earns $5B Q3 Core Profit On Strong Dupixent And Vaccine Sales, Raises 2024 Forecast
SNY

Benzinga

a month ago

Sanofi Earns $5B Q3 Core Profit On Strong Dupixent And Vaccine Sales, Raises 2024 Forecast

SNY

MT Newswires

a month ago

Sanofi Q3 Earnings, Sales Increase

Sanofi Earnings Get Boost From Early Vaccine Sales
SNY

The Wall Street Journal

a month ago

Sanofi Earnings Get Boost From Early Vaccine Sales

SNY

Associated Press Finance

a month ago

Sanofi: Q3 Earnings Snapshot

SNY

Investing.com

a month ago

Sanofi shares rise as Q3 results beat forecasts on vaccines and Beyfortus sales

Sanofi Profit Lifted by Early Vaccine Sales, Dupixent Growth
SNY

Bloomberg

a month ago

Sanofi Profit Lifted by Early Vaccine Sales, Dupixent Growth

Sanofi profit growth beats market view on early start of vaccine sales
SNY

Reuters

a month ago

Sanofi profit growth beats market view on early start of vaccine sales

Press Release: Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performance
SNY

GlobeNewswire

a month ago

Press Release: Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performance

SNY

MT Newswires

a month ago

Regeneron, Sanofi Report Dupixent 'Significantly' Reduced Itch, Hive Activity in Phase 3 Study for CSU

Press Release: Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI
SNY

GlobeNewswire

a month ago

Press Release: Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI

How Sanofi Was Caught in The Middle of a €16 Billion Public Brawl
SNY

Bloomberg

a month ago

How Sanofi Was Caught in The Middle of a €16 Billion Public Brawl

SNY

Morningstar Research

a month ago

Analyst Report: Sanofi

The Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi
SNY

Zacks

a month ago

The Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi

Sanofi Deal Jitters Imperil Stock’s Big Rebound
SNY

Barrons.com

a month ago

Sanofi Deal Jitters Imperil Stock’s Big Rebound

Sanofi Negotiating Exclusively With CD&R for Opella 50% Stake Sale
SNY

Zacks

a month ago

Sanofi Negotiating Exclusively With CD&R for Opella 50% Stake Sale

Sanofi’s $17bn sale of Opella to US investors advances following government deal
SNY

Pharmaceutical Technology

a month ago

Sanofi’s $17bn sale of Opella to US investors advances following government deal

SNY

MT Newswires

a month ago

Sector Update: Health Care Stocks Lean Lower Premarket Monday

Sanofi Engages In Exclusive Talks With US Private Equity CD&R For Its Consumer Health Business
SNY

Benzinga

a month ago

Sanofi Engages In Exclusive Talks With US Private Equity CD&R For Its Consumer Health Business

SNY

MT Newswires

a month ago

Sector Update: Health Care

Sanofi moves ahead with CD&R deal for stake in consumer business
SNY

BioPharma Dive

a month ago

Sanofi moves ahead with CD&R deal for stake in consumer business

SNY

MT Newswires

a month ago

Sanofi Enters Binding Talks to Sell Controlling Opella Stake to CD&R

SNY

Investing.com

a month ago

Sanofi and CD&R enter exclusive talks for Opella sale

CD&R Nears Sanofi OTC Deal After Signing With Government
SNY

Bloomberg

a month ago

CD&R Nears Sanofi OTC Deal After Signing With Government

Sanofi Enters Exclusive Talks With CD&R Over Opella Stake Sale
SNY

The Wall Street Journal

a month ago

Sanofi Enters Exclusive Talks With CD&R Over Opella Stake Sale

Sanofi enters exclusive talks with CD&R for Opella sale
SNY

Reuters

a month ago

Sanofi enters exclusive talks with CD&R for Opella sale

Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare
SNY

GlobeNewswire

a month ago

Press Release: Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcare

Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI
SNY

Reuters

a month ago

Sanofi to sell 51% stake in Opella to CD&R, 1% to BPI

SNY

MT Newswires

a month ago

Sector Update: Health Care

Pharma Stock Roundup: JNJ's Q3 Earnings, FDA Nod to Some New Drugs
SNY

Zacks

a month ago

Pharma Stock Roundup: JNJ's Q3 Earnings, FDA Nod to Some New Drugs

SNY

MT Newswires

a month ago

Market Chatter: Sanofi Nears Sale of Consumer Health to CD&R After Rival Bid

Sanofi Set to Sign Consumer Health Deal With CD&R This Weekend
SNY

Bloomberg

a month ago

Sanofi Set to Sign Consumer Health Deal With CD&R This Weekend

Sanofi and Orano Med link for radioligand therapy development
SNY

Pharmaceutical Technology

a month ago

Sanofi and Orano Med link for radioligand therapy development

SNY

MT Newswires

a month ago

Sanofi's Consumer Health Unit Opella Reportedly Draws Improved Offer from PAI Partners

Is Novavax Stock A Sell After An Unexpected Side Effect Torpedoed Its Testing Plans?
SNY

Investor's Business Daily

a month ago

Is Novavax Stock A Sell After An Unexpected Side Effect Torpedoed Its Testing Plans?

SNY Inks Deal With Orano Med for Next-Generation Radioligand Therapies
SNY

Zacks

a month ago

SNY Inks Deal With Orano Med for Next-Generation Radioligand Therapies

PAI Partners to Raise Offer for Sanofi’s Consumer Unit
SNY

Bloomberg

a month ago

PAI Partners to Raise Offer for Sanofi’s Consumer Unit

Novavax Stock Falls After FDA Puts Two Vaccine Programs on Hold
SNY

Zacks

a month ago

Novavax Stock Falls After FDA Puts Two Vaccine Programs on Hold

Sanofi, expanding in radiopharma, strikes a joint venture deal
SNY

BioPharma Dive

a month ago

Sanofi, expanding in radiopharma, strikes a joint venture deal

Exscientia advances two additional discovery programs with Sanofi
SNY

TipRanks

a month ago

Exscientia advances two additional discovery programs with Sanofi

Press Release: Sanofi and Orano join forces to develop next-generation radioligand medicines
SNY

GlobeNewswire

a month ago

Press Release: Sanofi and Orano join forces to develop next-generation radioligand medicines

SNY

MT Newswires

a month ago

Sanofi Gets FDA Approval to Update Flu Vaccine Label With New Pregnancy Safety Data

Goldman, Citi Among 22 Banks on CD&R’s Buyout of Sanofi Unit
SNY

Bloomberg

a month ago

Goldman, Citi Among 22 Banks on CD&R’s Buyout of Sanofi Unit

Sanofi in Talks With French Government to Address Concerns on Opella Deal
SNY

The Wall Street Journal

a month ago

Sanofi in Talks With French Government to Address Concerns on Opella Deal

FLUBLOK® (Influenza Vaccine) US label updated with one of Sanofi's largest flu vaccine safety studies in pregnant individuals
SNY

PR Newswire

a month ago

FLUBLOK® (Influenza Vaccine) US label updated with one of Sanofi's largest flu vaccine safety studies in pregnant individuals

SNY

MT Newswires

a month ago

Market Chatter: French Unions Call for Sanofi Strike Over Planned Consumer Health Sale

SNY

MT Newswires

a month ago

Exscientia Expects $15 Million in Milestone Payments From Sanofi

Sanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studies
SNY

PR Newswire

a month ago

Sanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studies

Top Analyst Reports for Alibaba, Linde & Abbott
SNY

Zacks

a month ago

Top Analyst Reports for Alibaba, Linde & Abbott

Share on Social Networks: